Work

1291eP Pola-R-CHP regimen as first-line treatment for newly diagnosed high-risk diffuse large B-cell lymphoma (DLBCL) patients

Year: 2025

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2025.08.1925

Authors: J. Pi, X. He, S. Zhou, P. Liu, J. Yang, G. Wei, T. Wang, J. Jin, Y. Lin, Q. Lv, W. Zhang

Institutions: Cancer Hospital of Huanxing Chaoyang District Beijing, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415939798

FWCI:

Cites:

Cited by:

Related to: 10